Blog

US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology – PR Newswire (press release)

US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology
PR Newswire (press release)
AzarGen has recently been featured on CB Insights' top global synthetic biology start-up companies market map list. AzarGen also recently expanded its collaboration with iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals

2017-07-12 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.